00:12:03 EST Wed 11 Dec 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Cannabis Summary for Nov. 12, 2019

2019-11-12 20:46 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The Canadian Securities Exchange Composite Index fell 5.19 points to 404.83 Tuesday, as the market gears up for third quarter results from a number of companies this week. Investors hoping for a rally in their battered cannabis stocks will be hoping that their old pets do indeed beat expectations. Things did not get off to a promising start yesterday after the market closed, when Organigram Holdings Inc. (OGI) reported that its fiscal fourth quarter (ended Aug. 31, 2019) net revenue would be about $16.3-million, down from $24.8-million in Q3. The company also said that it would have negative EBITDA for Q4, which would end a streak of four quarters with positive EBITDA. The cannabis grower said its problems in the fourth quarter were "exacerbated by increased industry supply," which of course will only get worse as licensed producers increase their growing capacities. As a result of the downgrade, Organigram sank 89 cents to a new 52-week low, $3.57, on 8.94 million shares today.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2019 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.